UnitedHealth Group Inc. (NYSE:UNH) is ripping higher Tuesday morning after a surprise Medicare Advantage reimbursement boost, pushing shares to the closely watched $300 level and forcing traders to reassess a badly damaged chart.

The stock's move follows a favorable CMS rate decision on Monday that flipped a major policy overhang into a modest tailwind, sparking aggressive dip-buying across managed care. 

But even with UNH trading above $300 in Tuesday's early action, the stock is still working to repair a deep primary downtrend, and the technicals suggest the next phase may be more grind than straight‑line recovery.

UNH Technicals

On the chart, UNH has rebounded sharply off its recent lows, with momentum finally turning in the bulls' favor. 

The chart below shows 2026 year-to-date price action and moving averages for UNH: 

The RSI (relative strength index) has pushed up to about 63.7, per Benzinga Pro data, reflecting strong short-term buying pressure but also creeping toward levels where prior rallies have stalled. 

UnitedHealth stock price is now knocking on the psychological $300 "wall," the lower edge of a broader resistance band stretching roughly from $300 to $400 where the last major breakdown began. 

That zone represents trapped supply from prior longs and an obvious battleground for the next leg and creates a well-defined playground for swing traders: support in the mid‑$260s, first resistance around $300, and range highs closer to $320 if momentum extends.

The chart below shows one-year price and moving averages data for UNH: 

Bulls vs. Bears

Fundamentally, the bull case leans on UnitedHealth's cost-cutting and earnings torque. 

Investors are betting AI-enabled efficiency and expense discipline can drive upside surprises when the company reports on April 21, potentially validating the idea that guidance was de‑risked at the bottom. 

On the other side, bears point to expected membership declines, especially in Medicare Advantage, where current projections call for a loss of roughly 1.3 million to 1.4 million members in 2026—far worse than earlier forecasts and a direct drag on scale and margins.

For now, the question isn't just whether UNH can tag $300, but whether it can hold above it long enough to start chipping away at that heavy $300 to $400 resistance ceiling.

UNH Price Action: According to data from Benzinga Pro, UnitedHealth stock was up 8.04% at $303.98 in early trading Tuesday.

Photo: PJ McDonnell / Shutterstock